XM无法为美国居民提供服务。
C
C

Cigna


市场新闻

U.S. STOCKS AppLovin, Regal Rexnord, Talkspace

BUZZ-U.S. STOCKS ON THE MOVE- AppLovin, Regal Rexnord, Talkspace Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes rose on Tuesday, with the S&P 500 hitting an intraday record high ahead of a crucial Federal Reserve interest-rate decision, after fresh economic data allayed worries of a sharp slowdown in the U.S.
A
C
I
M
N
S
U
U
D

Express Scripts sues FTC over drug pricing report, court documents show

UPDATE 2-Express Scripts sues FTC over drug pricing report Adds detail from the complaint and FTC comment in paragraphs 4-8, updates headline, byline and dateline By Jody Godoy NEW YORK, Sept 17 (Reuters) - Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report , calling the report's conclusion that the prescription middlemen raise drug costs defamatory.
C

Express Scripts sues FTC over drug pricing report, court documents show

Express Scripts sues FTC over drug pricing report, court documents show WASHINGTON, Sept 17 (Reuters) - Pharmacy benefit manager Express Scripts has sued the U.S. Federal Trade Commission over the regulator's recent drug pricing report , asking a court to force the agency to withdraw its findings, according to court documents filed on Tuesday. Repo
C

U.S. Aerovironment, Insulet, Viasat

U.S. RESEARCH ROUNDUP- Aerovironment, Insulet, Viasat Sept 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovironment, Insulet and Viasat, on Tuesday. HIGHLIGHTS * Aerovironment Inc AVAV.O : Raymond James cuts to market perform from outperform * Frontier Communications Parent Inc FYBR.O : JP Morgan cuts to neutral from overweight * Insulet Corp PODD.O : Piper Sandler raises target price to $285 from $230 * Relm
B
C
C
E
I
D

US employers expect nearly 6% spike in health insurance costs in 2025, Mercer says

US employers expect nearly 6% spike in health insurance costs in 2025, Mercer says By Amina Niasse NEW YORK, Sept 12 (Reuters) - U.S. employers expect health insurance costs to rise an average 5.8% in 2025, largely due to increased cost of medical services as well as higher use, according to a survey released by consulting firm Mercer on Thursday.
C

Cigna Healthcare Makes Virtual Care Even Easier And More Convenient With New E-Treatment Option From MDLIVE

BRIEF-Cigna Healthcare Makes Virtual Care Even Easier And More Convenient With New E-Treatment Option From MDLIVE Sept 12 (Reuters) - Cigna Group CI.N : CIGNA HEALTHCARE MAKES VIRTUAL CARE EVEN EASIER AND MORE CONVENIENT WITH NEW E-TREATMENT OPTION FROM MDLIVE Source text for Eikon: ID:nPn2lrgZga Further company coverage: CI.N
C

UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year

UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year By Patrick Wingrove Sept 10 (Reuters) - UnitedHealth Group UNH.N said on Tuesday it will remove AbbVie’s ABBV.N blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of Jan. 1, 2025, and recommend less expensive biosimilar versions of the medicine instead.
A
C
P
T

Portion of insured Americans was 92% in 2023, Census data shows

UPDATE 2-Portion of insured Americans was 92% in 2023, Census data shows Adds context on data in paragraph 3 and Medicare figure in paragraph 6 By Amina Niasse NEW YORK, Sept 10 (Reuters) - The portion of Americans who had health insurance for all or part of the year in 2023 was 92%, compared with 92.1% for all or part of 2022 according to a report released by the Census Bureau on Tuesday.
C

Proportion of Americans with health insurance was at 92% in 2023, Census data shows

Proportion of Americans with health insurance was at 92% in 2023, Census data shows NEW YORK, Sept 10 (Reuters) - The portion of Americans who had health insurance for all or part of the year fell slightly in 2023 to 92%, compared with 92.1% for all or part of 2022 according to a report released by the Census Bureau on Tuesday. The rate of Americans who are uninsured is set to rise to 8.9% over the next decade from 7.7% in 2024, the Congressional Budget Office said in a separate report released
C

More than 49 million in US covered by ACA over the past decade

More than 49 million in US covered by ACA over the past decade By Amina Niasse NEW YORK, Sept 10 (Reuters) - One in seven Americans have signed up for health insurance coverage through Affordable Care Act marketplaces since their 2014 launch, according to data released on Tuesday by the U.S. Department of the Treasury. A total of 49.4 million Americans have signed up for the plans, often referred to as Obamacare, with enrollment reaching a high of 20.8 million people in 2024, the agency said.
C

Biden administration finalizes rule to strengthen mental health parity law

Biden administration finalizes rule to strengthen mental health parity law By Amina Niasse NEW YORK, Sept 9 (Reuters) - The Biden Administration on Monday said it had finalized regulation to help ensure the 175 million Americans with private health insurance have access to affordable mental health services. The 2008 Mental Health Parity and Addiction Equity Act already requires insurers and corporate-backed health plans to provide access and payment structures for mental health care services on
C

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year

Cigna to remove AbbVie's Humira from some drug reimbursement lists next year By Patrick Wingrove Aug 26 (Reuters) - Cigna CI.N said on Monday it will remove AbbVie’s ABBV.N blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey biosimilar versions of the medicine instead.
A
C
P
T

U.S. Agree Realty, Global Payments, Snowflake

U.S. RESEARCH ROUNDUP- Agree Realty, Global Payments, Snowflake Aug 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Agree Realty, Global Payments and Snowflake on Wednesday. HIGHLIGHTS * Agree Realty Corp ADC.N : Raymond James raises target price to $81 from $70 * Coinbase Global Inc COIN.O : Jefferies cuts target price to $220 from $245 * Global Payments Inc GPN.N : Jefferies raises target price to $130 from $120
A
B
C
C
P
V
E
G
M
K
L

Venture capital firms making bets on maternal health

FOCUS-Venture capital firms making bets on maternal health By Amina Niasse NEW YORK, Aug 19 (Reuters) - After working as a doula for 10 years, Kortny Feutardo took her first Maryland Medicaid patient in January, providing the new mom with care coordination and counseling. Feutardo is one of many providers benefiting from growing investment in the maternal and neonatal health sector .
C

The Cigna Group Foundation Launches Grant Program To Improve Veteran Mental Health

BRIEF-The Cigna Group Foundation Launches Grant Program To Improve Veteran Mental Health Aug 12 (Reuters) - Cigna Group CI.N : THE CIGNA GROUP FOUNDATION LAUNCHES GRANT PROGRAM TO IMPROVE VETERAN MENTAL HEALTH Source text for Eikon: ID:nPn2HqD7a Further company coverage: CI.N ( Reuters.Briefs@thomsonreuters.com )
C

U.S. Booking Holdings, Doordash, Vertex Pharmaceuticals

U.S. RESEARCH ROUNDUP- Booking Holdings, Doordash, Vertex Pharmaceuticals Aug 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Booking Holdings, Doordash and Vertex Pharmaceuticals, on Monday. HIGHLIGHTS * Academy Sports and Outdoors Inc ASO.O : JP Morgan cuts to neutral from overweight * Booking Holdings Inc BKNG.O : Jefferies cuts target price to $4350 from $4650 * Doordash DASH.O : D.A.
A
B
C
C
C
C
E
V
E
A
B
C
C
C
C

Cigna falls after unchanged annual forecast despite profit beat

BUZZ-Cigna falls after unchanged annual forecast despite profit beat ** Shares of health insurer Cigna fall 4.8% to $331.80 ** Set for biggest one-day pct. fall since Nov. 2023 ** Co maintains its annual profit forecast after Q2 profit beat ** The lack of forecast raise despite the beat will be likely viewed as a modest disappointment - Leerink Partners ** Brokerage expects investors to keenly focus on determining if this resulted from more prudent posturing or a synthetic guide-down of the seco
C

Health insurer Cigna's cautious annual forecast spooks investors, shares fall

UPDATE 2-Health insurer Cigna's cautious annual forecast spooks investors, shares fall New throughout, adds details, background, analyst comments, updates share price By Amina Niasse and Sriparna Roy Aug 1 (Reuters) - Cigna CI.N took a cautious stance on its full-year profit outlook on Thursday despite reporting lower-than-feared medical costs in the second quarter and beating Wall Street's profit estimates, and the health insurer's shares fell more than 4%.
C

Fed nods to cut, chips rebound, BoE up next

MORNING BID AMERICAS-Fed nods to cut, chips rebound, BoE up next A look at the day ahead in U.S. and global markets from Mike Dolan The Federal Reserve left Wall Street with little doubt about a first U.S. interest rate cut in seven weeks' time, but multiple cross-currents from the earnings season , Japan and China, and domestic politics all make for a noisy start to August.
A
A
A
B
C
G
I
N
R
U
X
M
J
U
U
U
F
E
W
A
M

Cigna beats profit estimates on lower-than-expected costs, pharmacy benefit boost

Cigna beats profit estimates on lower-than-expected costs, pharmacy benefit boost Aug 1 (Reuters) - Cigna CI.N reported a second-quarter profit on Thursday that beat Wall Street estimates, helped by lower-than-expected medical costs and strength in its pharmacy benefit management unit. The industry has been contending with elevated medical costs since late last year, as older adults catch up on delayed procedures, and lower-than-expected payments from the government for managing healthcare for p
C



商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明